ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000225555.1	ABT-263 (navitoclax)	Skin cutaneous melanoma	0.007282475	Resistant
ENSG00000225555.1	ABT-263 (navitoclax)	Breast invasive carcinoma	0.011231608	Sensitive